Get your license here

Are you a  nonprofit research organization and want to access KeyGene’s intellectual property in a quick and easy way to make use of our innovative technologies? Here we offer you information and opportunities for licensing.

Sequence-Based Genotyping

Looking for a technology for simultaneously discovery and scoring of genetic markers without genome sequence information in a cost-effective way? Use KeyGene’s Sequence-Based Genotyping! Here you can obtain a license for using the SBG technology for internal research purposes. Download the form, fill in the required details and the return the form to our expert Michiel van Eijk. After payment of the licensing fee you will obtain the license. There is a licensing form for US and non-US nonprofit (RoW) research organizations.

Licensing form nonprofit research organizations US: Licensing form US
Licensing form nonprofit research organizations RoW: Licensing form RoW

Our current licensees include:

Licensees Europe:
– The James Hutton Institute
– University of Hohenheim
– University of Zürich
– University of Edinburgh
– Forschungszentrum Jülich
– Wageningen University
– ETH Zürich
– CNAG-CRG, Barcelona
– University of Liverpool
– WSL Swiss Federal Research Institute
– Aberystwyth University
– Julius Kühn-Institut

Licensees United States:
– University of Minnesota Genomics Center
– South Dakota State University
– Oregon State University
– Tennessee Technological University
– Samuel Roberts Noble Foundation
– San Diego Zoo Global
– North Carolina State University
– University of Delaware

If you are interested in a tailor-made licensing proposal for collaborative research projects or commercial application of SBG we advise you to contact our expert.

KeyGene’s SBG technology is protected by a global dominant patent portfolio (more information in this press release). This portfolio with granted and pending patents protects methods known as SBG, GBS, two-enzyme GBS, tunable GBS, RAD, ddRAD, 2b-RAD, SLAF-seq and related methods using restriction enzyme digestion and/or amplicon sequencing to produce complexity-reduced genome fractions sequenced with next-generation sequencing platforms.

Applications of KeyGene’s SBG technology in plants using tunable levels of complexity reduction have been published by Truong and co-workers (PLoS ONE, e37565, 2012) reporting double restriction enzyme digestion in Arabidopsis thaliana and triple digestion in lettuce. Van Poecke and co-workers (Plant Biotechnology Journal, 2013) published the use of SBG in durum wheat using double digestion in combination with a +2 selective primer to fine-tune the preferred level of complexity reduction.

KeyGene® SNPSelect

For details and forms to obtain a license to use the KeyGene® SNPSelect technology, please contact our expert for more information.